日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/01/13 | 1,135 | 1,142 | 1,127 | 1,134 | -1 | -0.1% | 144,000 |
| 2011/01/12 | 1,146 | 1,146 | 1,129 | 1,135 | -12 | -1% | 186,000 |
| 2011/01/11 | 1,143 | 1,149 | 1,139 | 1,147 | +15 | +1.3% | 186,000 |
| 2011/01/07 | 1,146 | 1,146 | 1,132 | 1,132 | -7 | -0.6% | 139,000 |
| 2011/01/06 | 1,144 | 1,146 | 1,136 | 1,139 | -4 | -0.3% | 137,000 |
| 2011/01/05 | 1,166 | 1,166 | 1,143 | 1,143 | -23 | -2% | 234,000 |
| 2011/01/04 | 1,174 | 1,174 | 1,140 | 1,166 | +4 | +0.3% | 280,000 |
| 2010/12/30 | 1,163 | 1,168 | 1,158 | 1,162 | -9 | -0.8% | 134,000 |
| 2010/12/29 | 1,161 | 1,176 | 1,153 | 1,171 | +11 | +0.9% | 163,000 |
| 2010/12/28 | 1,154 | 1,166 | 1,145 | 1,160 | +7 | +0.6% | 104,000 |
| 2010/12/27 | 1,169 | 1,179 | 1,151 | 1,153 | -13 | -1.1% | 342,000 |
| 2010/12/24 | 1,147 | 1,170 | 1,143 | 1,166 | +30 | +2.6% | 370,000 |
| 2010/12/22 | 1,130 | 1,143 | 1,130 | 1,136 | +7 | +0.6% | 244,000 |
| 2010/12/21 | 1,118 | 1,134 | 1,118 | 1,129 | +18 | +1.6% | 199,000 |
| 2010/12/20 | 1,106 | 1,124 | 1,106 | 1,111 | -4 | -0.4% | 345,000 |
| 2010/12/17 | 1,110 | 1,121 | 1,103 | 1,115 | +5 | +0.5% | 234,000 |
| 2010/12/16 | 1,119 | 1,119 | 1,090 | 1,110 | -2 | -0.2% | 389,000 |
| 2010/12/15 | 1,103 | 1,112 | 1,100 | 1,112 | +11 | +1% | 169,000 |
| 2010/12/14 | 1,112 | 1,112 | 1,090 | 1,101 | -11 | -1% | 198,000 |
| 2010/12/13 | 1,111 | 1,113 | 1,101 | 1,112 | +2 | +0.2% | 140,000 |
| 2010/12/10 | 1,104 | 1,112 | 1,095 | 1,110 | -3 | -0.3% | 242,000 |
| 2010/12/09 | 1,104 | 1,116 | 1,104 | 1,113 | -1 | -0.1% | 132,000 |
| 2010/12/08 | 1,110 | 1,119 | 1,099 | 1,114 | +10 | +0.9% | 182,000 |
| 2010/12/07 | 1,088 | 1,105 | 1,088 | 1,104 | +4 | +0.4% | 146,000 |
| 2010/12/06 | 1,093 | 1,107 | 1,093 | 1,100 | +1 | +0.1% | 105,000 |
| 2010/12/03 | 1,090 | 1,111 | 1,090 | 1,099 | +7 | +0.6% | 203,000 |
| 2010/12/02 | 1,116 | 1,116 | 1,086 | 1,092 | -6 | -0.5% | 204,000 |
| 2010/12/01 | 1,097 | 1,103 | 1,090 | 1,098 | +7 | +0.6% | 86,000 |
| 2010/11/30 | 1,104 | 1,108 | 1,088 | 1,091 | -12 | -1.1% | 281,000 |
| 2010/11/29 | 1,113 | 1,121 | 1,098 | 1,103 | -13 | -1.2% | 267,000 |
| 2010/11/26 | 1,130 | 1,130 | 1,115 | 1,116 | -5 | -0.4% | 57,000 |
| 2010/11/25 | 1,128 | 1,128 | 1,116 | 1,121 | +5 | +0.4% | 207,000 |
| 2010/11/24 | 1,118 | 1,135 | 1,113 | 1,116 | -4 | -0.4% | 226,000 |
| 2010/11/22 | 1,122 | 1,122 | 1,112 | 1,120 | +9 | +0.8% | 98,000 |
| 2010/11/19 | 1,134 | 1,134 | 1,102 | 1,111 | -23 | -2% | 345,000 |
| 2010/11/18 | 1,105 | 1,137 | 1,104 | 1,134 | +23 | +2.1% | 224,000 |
| 2010/11/17 | 1,107 | 1,114 | 1,102 | 1,111 | +4 | +0.4% | 93,000 |
| 2010/11/16 | 1,127 | 1,129 | 1,102 | 1,107 | -19 | -1.7% | 230,000 |
| 2010/11/15 | 1,134 | 1,135 | 1,121 | 1,126 | +4 | +0.4% | 140,000 |
| 2010/11/12 | 1,135 | 1,140 | 1,121 | 1,122 | -9 | -0.8% | 212,000 |
| 2010/11/11 | 1,153 | 1,153 | 1,115 | 1,131 | -13 | -1.1% | 269,000 |
| 2010/11/10 | 1,153 | 1,161 | 1,135 | 1,144 | +4 | +0.4% | 170,000 |
| 2010/11/09 | 1,135 | 1,150 | 1,127 | 1,140 | +6 | +0.5% | 218,000 |
| 2010/11/08 | 1,127 | 1,137 | 1,115 | 1,134 | +11 | +1% | 330,000 |
| 2010/11/05 | 1,166 | 1,171 | 1,122 | 1,123 | -23 | -2% | 331,000 |
| 2010/11/04 | 1,128 | 1,155 | 1,112 | 1,146 | +19 | +1.7% | 636,000 |
| 2010/11/02 | 1,123 | 1,134 | 1,111 | 1,127 | -2 | -0.2% | 233,000 |
| 2010/11/01 | 1,137 | 1,144 | 1,124 | 1,129 | -11 | -1% | 175,000 |
| 2010/10/29 | 1,137 | 1,148 | 1,113 | 1,140 | -5 | -0.4% | 314,000 |
| 2010/10/28 | 1,152 | 1,167 | 1,133 | 1,145 | -19 | -1.6% | 321,000 |
3501～
3550
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
